Purpose Advancements in the endovascular treatment of femoropopliteal atherosclerotic
lesions have led to treatment of more complex lesions, particularly long lesions. The aim of …

Background Revascularization is being used increasingly for the treatment of intermittent
claudication and yet few studies have reported the long-term outcomes of this strategy. The …

Background Mesenteric artery stenting with a bare-metal stent is the current treatment for
atherosclerotic chronic mesenteric ischaemia. Long-term patency of bare-metal stents is …

Endovascular therapy (EVT) of symptomatic peripheral artery disease (PAD) offers relief of
symptoms and enhanced quality of life. Advancements in technique and technology have …

Objective Stent grafts (SG) and drug eluting stents (DES) have emerged to combat intimal
hyperplasia. It remains unclear which type of stent yields superior outcomes in …

Objectives This study sought to elucidate the clinical impact and prognosis of stent graft (SG)
thrombosis. Background The VIABAHN SG offers a favorable outcome in long peripheral …

Objective: High on-treatment platelet reactivity (HTPR) to dual antiplatelet therapy (DAPT)
predicts adverse events in coronary artery disease patients. In peripheral artery disease …

Aims: The aims of this study were to assess the incidence and predictors of superficial
femoral artery (SFA) stent thrombosis (ST) in a large patient cohort. Methods and results: A …

Purpose We aimed to evaluate the impact of intrinsic coagulation factors and hemostatic
markers of endothelial dysfunction on complications in patients with atherosclerotic …

Objective Covered stents (CS) to treat superficial femoral artery (SFA) occlusive disease
have become more common. However, concerns about patients presenting with acute limb …